Opportunistic infection improvements level off.
One of the greatest achievements of protease inhibitor and highly active antiretroviral therapy has been the dramatic decrease in the incidence of opportunistic infections (OIs) related to AIDS. In the first couple of years after the advent of PI therapy, clinicians found that fewer HIV/AIDS patients developed some of the more common OIs, such as Kaposi's sarcoma and pneumocystosis. However, new research shows that the decline in OI rates has ended.